Pancreatic ductal adenocarcinoma complete regression after preoperative chemotherapy: Surgical results in a small series

Background: Pancreatic ductal adenocarcinoma (PDAC) becomes a systemic disease from an early stage. Complete surgical resection remains the only validated and potentially curative treatment; disappointingly only 20% of patients present with a resectable tumour. Although a complete pathological regre...

Full description

Bibliographic Details
Main Authors: Domenico Pinelli, Andrea Micalef, Barbara Merelli, Rosangela Trezzi, Annalisa Amaduzzi, Stefano Agnesi, Michela Guizzetti, Stefania Camagni, Veronica Fedele, Michele Colledan
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294223000928